Europe Conjugated Drug Market Research Report Forecast 2017 to 2022

November 2017 | 132 pages | ID: E5C5BDB39ECEN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Europe Conjugated Drug Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Conjugated Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Conjugated Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Conjugated Drug Market Analysis by Countries:
Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:
CSL Ltd. (Australia)
Grifols S.A (Spain)
Baxalta Incorporated (U.S.)
Octapharma AG (Switzerland)
Kedrion S.p.A (Italy)
China Biologic Products, Inc. (China)
Biotest AG (Germany)
LFB S.A (France)
Bio Product Laboratory Ltd. (U.K.)

Europe Conjugated Drug Market Analysis by Product:
Type 1
Type 2
Type 3

Europe Conjugated Drug Market Analysis by Application:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 CONJUGATED DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Conjugated Drug
1.2 Classification of Conjugated Drug
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Conjugated Drug
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Conjugated Drug Market States Status and Prospect (2012-2022) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Conjugated Drug (2012-2022)
  1.5.1 Europe Conjugated Drug Sales and Growth Rate (2012-2022)
  1.5.2 Europe Conjugated Drug Revenue and Growth Rate (2012-2022)

2 EUROPE ECONOMIC IMPACT ON CONJUGATED DRUG INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 CONJUGATED DRUG MANUFACTURING COST ANALYSIS

3.1 Conjugated Drug Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Conjugated Drug

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Conjugated Drug Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Conjugated Drug Major Manufacturers in 2016
4.4 Downstream Buyers

5 EUROPE CONJUGATED DRUG MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Conjugated Drug Market Competition by Manufacturers
  5.1.1 Europe Conjugated Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Conjugated Drug Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Conjugated Drug (Volume and Value) by Type
  5.2.1 Europe Conjugated Drug Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Conjugated Drug Revenue and Market Share by Type (2012-2017)
5.3 Europe Conjugated Drug (Volume and Value) by Countries
  5.3.1 Europe Conjugated Drug Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Conjugated Drug Revenue and Market Share by Countries (2012-2017)
5.4 Europe Conjugated Drug (Volume) by Application

6 GERMANY CONJUGATED DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Conjugated Drug Sales and Value (2012-2017)
  6.1.1 Germany Conjugated Drug Sales and Growth Rate (2012-2017)
  6.1.2 Germany Conjugated Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Conjugated Drug Sales Price Trend (2012-2017)
6.2 Germany Conjugated Drug Sales and Market Share by Manufacturers
6.3 Germany Conjugated Drug Sales and Market Share by Type
6.4 Germany Conjugated Drug Sales and Market Share by Application

7 FRANCE CONJUGATED DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 France Conjugated Drug Sales and Value (2012-2017)
  7.1.1 France Conjugated Drug Sales and Growth Rate (2012-2017)
  7.1.2 France Conjugated Drug Revenue and Growth Rate (2012-2017)
  7.1.3 France Conjugated Drug Sales Price Trend (2012-2017)
7.2 France Conjugated Drug Sales and Market Share by Manufacturers
7.3 France Conjugated Drug Sales and Market Share by Type
7.4 France Conjugated Drug Sales and Market Share by Application

8 UK CONJUGATED DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 UK Conjugated Drug Sales and Value (2012-2017)
  8.1.1 UK Conjugated Drug Sales and Growth Rate (2012-2017)
  8.1.2 UK Conjugated Drug Revenue and Growth Rate (2012-2017)
  8.1.3 UK Conjugated Drug Sales Price Trend (2012-2017)
8.2 UK Conjugated Drug Sales and Market Share by Manufacturers
8.3 UK Conjugated Drug Sales and Market Share by Type
8.4 UK Conjugated Drug Sales and Market Share by Application

9 RUSSIA CONJUGATED DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Conjugated Drug Sales and Value (2012-2017)
  9.1.1 Russia Conjugated Drug Sales and Growth Rate (2012-2017)
  9.1.2 Russia Conjugated Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Conjugated Drug Sales Price Trend (2012-2017)
9.2 Russia Conjugated Drug Sales and Market Share by Manufacturers
9.3 Russia Conjugated Drug Sales and Market Share by Type
9.4 Russia Conjugated Drug Sales and Market Share by Application

10 ITALY CONJUGATED DRUG (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Conjugated Drug Sales and Value (2012-2017)
  10.1.1 Italy Conjugated Drug Sales and Growth Rate (2012-2017)
  10.1.2 Italy Conjugated Drug Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Conjugated Drug Sales Price Trend (2012-2017)
10.2 Italy Conjugated Drug Sales and Market Share by Manufacturers
10.3 Italy Conjugated Drug Sales and Market Share by Type
10.4 Italy Conjugated Drug Sales and Market Share by Application

11 SPAIN CONJUGATED DRUG (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Conjugated Drug Sales and Value (2012-2017)
  11.1.1 Spain Conjugated Drug Sales and Growth Rate (2012-2017)
  11.1.2 Spain Conjugated Drug Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Conjugated Drug Sales Price Trend (2012-2017)
11.2 Spain Conjugated Drug Sales and Market Share by Manufacturers
11.3 Spain Conjugated Drug Sales and Market Share by Type
11.4 Spain Conjugated Drug Sales and Market Share by Application

12 BENELUX CONJUGATED DRUG (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Conjugated Drug Sales and Value (2012-2017)
  12.1.1 Benelux Conjugated Drug Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Conjugated Drug Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Conjugated Drug Sales Price Trend (2012-2017)
12.2 Benelux Conjugated Drug Sales and Market Share by Manufacturers
12.3 Benelux Conjugated Drug Sales and Market Share by Type
12.4 Benelux Conjugated Drug Sales and Market Share by Application

13 EUROPE CONJUGATED DRUG MANUFACTURERS ANALYSIS

13.1 CSL Ltd. (Australia)
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Grifols S.A (Spain)
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Baxalta Incorporated (U.S.)
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Octapharma AG (Switzerland)
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Kedrion S.p.A (Italy)
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 China Biologic Products, Inc. (China)
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Biotest AG (Germany)
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 LFB S.A (France)
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Bio Product Laboratory Ltd. (U.K.)
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE CONJUGATED DRUG MARKET FORECAST (2017-2022)

15.1 Germany Market Forecast (2017-2022)
15.2 France Market Forecast (2017-2022)
15.3 UK Market Forecast (2017-2022)
15.4 Russia Market Forecast (2017-2022)
15.5 Italy Market Forecast (2017-2022)
15.6 Spain Market Forecast (2017-2022)
15.7 Benelux Market Forecast (2017-2022)
15.8 Europe Conjugated Drug Market Forecast by Type (2017-2022)
15.9 Europe Conjugated Drug Market Forecast by Application (2017-2022)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Conjugated Drug
Table Classification of Conjugated Drug
Figure Europe Sales Market Share of Conjugated Drug by Type in 2016
Table Application of Conjugated Drug
Figure Europe Sales Market Share of Conjugated Drug by Application in 2016
Figure Germany Conjugated Drug Revenue and Growth Rate (2012-2022)
Figure France Conjugated Drug Revenue and Growth Rate (2012-2022)
Figure UK Conjugated Drug Revenue and Growth Rate (2012-2022)
Figure Russia Conjugated Drug Revenue and Growth Rate (2012-2022)
Figure Italy Conjugated Drug Revenue and Growth Rate (2012-2022)
Figure Spain Conjugated Drug Revenue and Growth Rate (2012-2022)
Figure Benelux Conjugated Drug Revenue and Growth Rate (2012-2022)
Figure Europe Conjugated Drug Sales and Growth Rate (2012-2022)
Figure Europe Conjugated Drug Revenue and Growth Rate (2012-2022)
Table Europe Conjugated Drug Sales of Key Manufacturers (2015 and 2016)
Table Europe Conjugated Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Conjugated Drug Sales Share by Manufacturers
Figure 2016 Conjugated Drug Sales Share by Manufacturers
Table Europe Conjugated Drug Revenue by Manufacturers (2015 and 2016)
Table Europe Conjugated Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Conjugated Drug Revenue Share by Manufacturers
Table 2016 Europe Conjugated Drug Revenue Share by Manufacturers
Table Europe Conjugated Drug Sales and Market Share by Type (2012-2017)
Table Europe Conjugated Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Conjugated Drug by Type (2012-2017)
Figure Europe Conjugated Drug Sales Growth Rate by Type (2012-2017)
Table Europe Conjugated Drug Revenue and Market Share by Type (2012-2017)
Table Europe Conjugated Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Conjugated Drug by Type (2012-2017)
Figure Europe Conjugated Drug Revenue Growth Rate by Type (2012-2017)
Table Europe Conjugated Drug Sales and Market Share by Countries (2012-2017)
Table Europe Conjugated Drug Sales Share by Countries (2012-2017)
Figure Sales Market Share of Conjugated Drug by Countries (2012-2017)
Table Europe Conjugated Drug Revenue and Market Share by Countries (2012-2017)
Table Europe Conjugated Drug Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Conjugated Drug by Countries (2012-2017)
Table Europe Conjugated Drug Sales and Market Share by Application (2012-2017)
Table Europe Conjugated Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Conjugated Drug by Application (2012-2017)
Figure Germany Conjugated Drug Sales and Growth Rate (2012-2017)
Figure Germany Conjugated Drug Revenue and Growth Rate (2012-2017)
Figure Germany Conjugated Drug Sales Price Trend (2012-2017)
Table Germany Conjugated Drug Sales by Manufacturers (2015 and 2016)
Table Germany Conjugated Drug Market Share by Manufacturers (2015 and 2016)
Table Germany Conjugated Drug Sales by Type (2015 and 2016)
Table Germany Conjugated Drug Market Share by Type (2015 and 2016)
Table Germany Conjugated Drug Sales by Application (2015 and 2016)
Table Germany Conjugated Drug Market Share by Application (2015 and 2016)
Figure France Conjugated Drug Sales and Growth Rate (2012-2017)
Figure France Conjugated Drug Revenue and Growth Rate (2012-2017)
Figure France Conjugated Drug Sales Price Trend (2012-2017)
Table France Conjugated Drug Sales by Manufacturers (2015 and 2016)
Table France Conjugated Drug Market Share by Manufacturers (2015 and 2016)
Table France Conjugated Drug Sales by Type (2015 and 2016)
Table France Conjugated Drug Market Share by Type (2015 and 2016)
Table France Conjugated Drug Sales by Application (2015 and 2016)
Table France Conjugated Drug Market Share by Application (2015 and 2016)
Figure UK Conjugated Drug Sales and Growth Rate (2012-2017)
Figure UK Conjugated Drug Revenue and Growth Rate (2012-2017)
Figure UK Conjugated Drug Sales Price Trend (2012-2017)
Table UK Conjugated Drug Sales by Manufacturers (2015 and 2016)
Table UK Conjugated Drug Market Share by Manufacturers (2015 and 2016)
Table UK Conjugated Drug Sales by Type (2015 and 2016)
Table UK Conjugated Drug Market Share by Type (2015 and 2016)
Table UK Conjugated Drug Sales by Application (2015 and 2016)
Table UK Conjugated Drug Market Share by Application (2015 and 2016)
Figure Russia Conjugated Drug Sales and Growth Rate (2012-2017)
Figure Russia Conjugated Drug Revenue and Growth Rate (2012-2017)
Figure Russia Conjugated Drug Sales Price Trend (2012-2017)
Table Russia Conjugated Drug Sales by Manufacturers (2015 and 2016)
Table Russia Conjugated Drug Market Share by Manufacturers (2015 and 2016)
Table Russia Conjugated Drug Sales by Type (2015 and 2016)
Table Russia Conjugated Drug Market Share by Type (2015 and 2016)
Table Russia Conjugated Drug Sales by Application (2015 and 2016)
Table Russia Conjugated Drug Market Share by Application (2015 and 2016)
Figure Italy Conjugated Drug Sales and Growth Rate (2012-2017)
Figure Italy Conjugated Drug Revenue and Growth Rate (2012-2017)
Figure Italy Conjugated Drug Sales Price Trend (2012-2017)
Table Italy Conjugated Drug Sales by Manufacturers (2015 and 2016)
Table Italy Conjugated Drug Market Share by Manufacturers (2015 and 2016)
Table Italy Conjugated Drug Sales by Type (2015 and 2016)
Table Italy Conjugated Drug Market Share by Type (2015 and 2016)
Table Italy Conjugated Drug Sales by Application (2015 and 2016)
Table Italy Conjugated Drug Market Share by Application (2015 and 2016)
Figure Spain Conjugated Drug Sales and Growth Rate (2012-2017)
Figure Spain Conjugated Drug Revenue and Growth Rate (2012-2017)
Figure Spain Conjugated Drug Sales Price Trend (2012-2017)
Table Spain Conjugated Drug Sales by Manufacturers (2015 and 2016)
Table Spain Conjugated Drug Market Share by Manufacturers (2015 and 2016)
Table Spain Conjugated Drug Sales by Type (2015 and 2016)
Table Spain Conjugated Drug Market Share by Type (2015 and 2016)
Table Spain Conjugated Drug Sales by Application (2015 and 2016)
Table Spain Conjugated Drug Market Share by Application (2015 and 2016)
Figure Benelux Conjugated Drug Sales and Growth Rate (2012-2017)
Figure Benelux Conjugated Drug Revenue and Growth Rate (2012-2017)
Figure Benelux Conjugated Drug Sales Price Trend (2012-2017)
Table Benelux Conjugated Drug Sales by Manufacturers (2015 and 2016)
Table Benelux Conjugated Drug Market Share by Manufacturers (2015 and 2016)
Table Benelux Conjugated Drug Sales by Type (2015 and 2016)
Table Benelux Conjugated Drug Market Share by Type (2015 and 2016)
Table Benelux Conjugated Drug Sales by Application (2015 and 2016)
Table Benelux Conjugated Drug Market Share by Application (2015 and 2016)
Table CSL Ltd. (Australia) Basic Information List
Table CSL Ltd. (Australia) Conjugated Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CSL Ltd. (Australia) Conjugated Drug Sales Market Share (2012-2017)
Table Grifols S.A (Spain) Basic Information List
Table Grifols S.A (Spain) Conjugated Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Grifols S.A (Spain) Conjugated Drug Sales Market Share (2012-2017)
Table Baxalta Incorporated (U.S.) Basic Information List
Table Baxalta Incorporated (U.S.) Conjugated Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Baxalta Incorporated (U.S.) Conjugated Drug Sales Market Share (2012-2017)
Table Octapharma AG (Switzerland) Basic Information List
Table Octapharma AG (Switzerland) Conjugated Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Octapharma AG (Switzerland) Conjugated Drug Sales Market Share (2012-2017)
Table Kedrion S.p.A (Italy) Basic Information List
Table Kedrion S.p.A (Italy) Conjugated Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Kedrion S.p.A (Italy) Conjugated Drug Sales Market Share (2012-2017)
Table China Biologic Products, Inc. (China) Basic Information List
Table China Biologic Products, Inc. (China) Conjugated Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table China Biologic Products, Inc. (China) Conjugated Drug Sales Market Share (2012-2017)
Table Biotest AG (Germany) Basic Information List
Table Biotest AG (Germany) Conjugated Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biotest AG (Germany) Conjugated Drug Sales Market Share (2012-2017)
Table LFB S.A (France) Basic Information List
Table LFB S.A (France) Conjugated Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table LFB S.A (France) Conjugated Drug Sales Market Share (2012-2017)
Table Bio Product Laboratory Ltd. (U.K.) Basic Information List
Table Bio Product Laboratory Ltd. (U.K.) Conjugated Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bio Product Laboratory Ltd. (U.K.) Conjugated Drug Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Conjugated Drug
Figure Manufacturing Process Analysis of Conjugated Drug
Figure Conjugated Drug Industrial Chain Analysis
Table Raw Materials Sources of Conjugated Drug Major Manufacturers in 2016
Table Major Buyers of Conjugated Drug
Table Distributors/Traders List
Figure Germany Conjugated Drug Sales and Growth Rate Forecast (2017-2022)
Figure Germany Conjugated Drug Revenue and Growth Rate Forecast (2017-2022)
Figure France Conjugated Drug Sales and Growth Rate Forecast (2017-2022)
Figure France Conjugated Drug Revenue and Growth Rate Forecast (2017-2022)
Figure UK Conjugated Drug Sales and Growth Rate Forecast (2017-2022)
Figure UK Conjugated Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Conjugated Drug Sales and Growth Rate Forecast (2017-2022)
Figure Russia Conjugated Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Conjugated Drug Sales and Growth Rate Forecast (2017-2022)
Figure Italy Conjugated Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Conjugated Drug Sales and Growth Rate Forecast (2017-2022)
Figure Spain Conjugated Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Conjugated Drug Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Conjugated Drug Revenue and Growth Rate Forecast (2017-2022)
Table Europe Conjugated Drug Sales Forecast by Type (2017-2022)
Table Europe Conjugated Drug Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

CSL Ltd. (Australia)
Grifols S.A (Spain)
Baxalta Incorporated (U.S.)
Octapharma AG (Switzerland)
Kedrion S.p.A (Italy)
China Biologic Products, Inc. (China)
Biotest AG (Germany)
LFB S.A (France)
Bio Product Laboratory Ltd. (U.K.)
Sanquin (Netherlands)